The IMCB was established in 1987 at the National University of Singapore before becoming an autonomous research institute of A*STAR and moving to Biopolis in 2004. The IMCB strives to maintain the scientific excellence of principal investigator-driven research and at the same time aims to promote collaborative team-based projects of medical and industrial relevance. Funded primarily by the A*STAR Biomedical Research Council, the IMCB’s research activities focus on four major fields: animal models of development and disease, cancer genetics and therapeutics, cell biology in health and disease, and structural biology and drug discovery.
Ng YiZhen
15 May 2019IMB was formed in 2007, with a mission to study mechanisms of human disease in
